Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, and Valo ...

Lisata Therapeutics (LSTA) and Valo Therapeutics announced a preclinical research collaboration to investigate the benefits of combining ...

Researchers have also found that it can protect the skin from UV radiation, reducing the risk of melanoma. ...

Caffeine, found in coffee and tea, has numerous benefits: it enhances concentration, improves mood, boosts metabolism, and ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

Using a mouse model, the first stage was a thorough investigation of changes in the mice with subcutaneous melanoma (below ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T cells -; which have lost their cancer-fighting oomph -; consume this lactic ...

“We have already shown that this is possible in mouse models of glioblastoma and together, we will now translate this finding ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.